ANTIVIRALE AGENTIEN ZUR PRÄVENTION UND/ODER BEHANDLUNG VON DURCH ALPHA- UND/ODER BETA-CORONAVIREN VERURSACHTEN PATHOLOGIEN

European patent · EP4267149 · In force

Register entry

Publication number
EP4267149
Application number
EP21835861
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 22, 2021
Published
Nov 1, 2023
Granted
Aug 28, 2024
Protection ends at the latest
Dec 21, 2041
Next annual fee due
Dec 31, 2026
IPC classes
A61K 31/728 (2006.01)
A61K 9/12 (2006.01)
A61P 31/14 (2006.01)
A61K 31/737 (2006.01)
A61K 9/00 (2006.01)
A61K 47/10 (2017.01)
Priority
IT 202000032243 23.12.2020
PCT application
PCT/IB2021/062161 22.12.2021
PCT publication
WO2022/137147 30.06.2022
Filing language
Italian
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Jul 9, 2025

    Change

    Published in Swissreg on 09.07.2025

  3. Jan 8, 2025

    Change

    Published in Swissreg on 08.01.2025

  4. Oct 3, 2024

    Agent entered

    Representative
    VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 03.10.2024

  5. Aug 28, 2024

    Granted

    Published in Swissreg on 28.08.2024

Parties

Holder

Fidia Farmaceutici S.p.A.

Via Ponte della Fabbrica 3/A, 35031 Abano Terme (PD), IT

Agent

VALIPAT c/o BOVARD LTD

Optingenstrasse 16, 3013 Bern

Inventor

PIZZOCARO, Carlo

35031 Abano Terme (PD), IT

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.